Articles by Disease (Lymphoma)

Oxidized LDL Antibodies in Treatment and Risk Assessment of Atherosclerosis and Associated Cardiovascular Disease

Journal: Current Pharmaceutical Design
Volume: 13
Page: 1021-1030
Author(s): Jan Nilsson, Gunilla Nordin Fredrikson, Alexandru Schiopu, Prediman K. Shah, Bo Jansson and Roland Carlsson

Targeting the Methyl Erythritol Phosphate (MEP) Pathway for Novel Antimalarial, Antibacterial and Herbicidal Drug Discovery: Inhibition of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase (DXR) Enzyme

Journal: Current Pharmaceutical Design
Volume: 13
Page: 1161-1177
Author(s): Nidhi Singh, Gweneal Cheve, Mitchell A. Avery and Christopher R. McCurdy

The Two fACEs of the Tissue Renin-Angiotensin Systems: Implication in Cardiovascular Diseases

Journal: Current Pharmaceutical Design
Volume: 13
Page: 1231-1245
Author(s): Eric Lazartigues, Yumei Feng and Julie L. Lavoie

The Protease of Human T-Cell Leukemia Virus Type-1 is a Potential Therapeutic Target

Journal: Current Pharmaceutical Design
Volume: 13
Page: 1285-1294
Author(s): Jozsef Tozser and Irene T. Weber

mTOR Inhibition in Lymphoma: A Rational and Promising Strategy

Journal: Letters in Drug Design & Discovery
Volume: 4
Page: 224-231
Author(s): Sonali M. Smith and Koen van Besien

Microwave Assisted Medicinal Chemistry

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7
Page: 345-369
Author(s): Jesus Alcazar, Gaston Diels and Bruno Schoentjes

The Role of Bax/Bcl-2 and Pro-Caspase Peptides in Hypoxia/Reperfusion-Dependent Regulation of MAPKERK: Discordant Proteomic Effect of MAPKp38

Journal: Protein & Peptide Letters
Volume: 14
Page: 361-371
Author(s): John J. Haddad